학술논문
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
Document Type
Article
Author
Battipaglia, G.; Mauff, K.; Wendel, L.; Angelucci, E.; Mohty, M.; Arcese, W.; Santarone, S.; Rubio, M.T.; Kroger, N.; Fox, M.L.; Blaise, D.; Iori, A.P.; Fanin, R.; Chalandon, Y.; Pioltelli, P.; Marotta, G.; Chiusolo, P.; Sever, M.; Solano, C.; Hernandez-Boluda, J.C.; Contentin, N.; de Wreede, L.C.; Czerw, T.; Hayden, P.; McLornan, D.; Yakoub-Agha, I.
Source
In: Bone Marrow Transplantation . (Bone Marrow Transplantation, July 2021, 56(7):1593-1602)
Subject
Language
English
ISSN
14765365
02683369
02683369